Showing results (21-30 of 53) with videos related to

Sort By:
Pageof 6
Current Medicinal Chemistry|February 16, 2023
Abrocitinib: First Globally Approved Selective Janus Kinase-1 Inhibitor for the Treatment of Atopic DermatitisSurya K De
Endocrine, Metabolic & Immune Disorders Drug Targets|February 21, 2023
Novel 2,4- diaminopyrimidine 5-carboxamides as c-Jun <i>N</i>-terminal Kinase Inhibitors for Treating the Liver Fibrotic DisorderSurya K De
Current Medicinal Chemistry|March 24, 2023
Ganaxolone: First FDA-approved Medicine for the Treatment of Seizures Associated with Cyclin-dependent Kinase-like 5 Deficiency DisorderSurya K De
Current Medicinal Chemistry|May 26, 2023
Pyrazolo[4,3-H]quinazolines as Cyclin-dependent Kinase Inhibitors for Treating CancerSurya K De
Current Medicinal Chemistry|October 11, 2023
Pirtobrutinib: First Non-covalent Tyrosine Kinase Inhibitor for Treating Relapsed or Refractory Mantle Cell Lymphoma in AdultsSurya K De
Pharmaceutical Patent Analyst|November 19, 2013
PDK1 inhibitorsElisa Barile, Surya K De, Maurizio Pellecchia
Chemmedchem|November 24, 2015
High-Throughput Screening (HTS) by NMR Guided Identification of Novel Agents Targeting the Protein Docking Domain of YopHAngel Bottini, Bainan Wu, Elisa Barile, et al.
Current Topics in Medicinal Chemistry|May 20, 2015
High-Throughput Screening by Nuclear Magnetic Resonance (HTS by NMR) for the Identification of PPIs AntagonistsBainan Wu, Elisa Barile, Surya K De, et al.
Chemical Biology & Drug Design|February 14, 2015
Targeting Influenza A Virus RNA PromoterAngel Bottini, Surya K De, Bainan Wu, et al.
Chemical Biology & Drug Design|June 25, 2013
Synthesis and SAR studies of dual AKT/NF-κB inhibitors against melanomaElisa Barile, Surya K De, Yongmei Feng, et al.
Pageof 6